All News
Filter News
Found 806,077 articles
-
Chardan's Equity Research Team Publishes in a Peer-reviewed Journal
12/18/2018
Chardan, a global investment bank, announced today that the peer-reviewed journal, Human Gene Therapy Clinical Development, published a perspective authored by analysts in the firm's equity research department.
-
Genomic Health to Present at the 37th Annual J.P. Morgan Healthcare Conference
12/18/2018
Genomic Health, Inc. (NASDAQ: GHDX) today announced that Kim Popovits, chairman of the board, chief executive officer and president, will present at the 37th Annual J.P. Morgan Healthcare Conference at the Westin St. Francis Hotel in San Francisco on Monday, January 7, 2019 at 11:30 a.m. Pacific Time.
-
Monteris Medical Announces Anthem, Inc. Has Developed Clinical Utilization Management Guidelines for its NeuroBlate® System Laser Interstitial Thermotherapy for Refractory Epilepsy
12/18/2018
Monteris Medical, the leader in image-guided laser interstitial thermotherapy (LITT), is pleased to announce that health insurance provider Anthem, Inc. has established Clinical Utilization Management (UM) Guidelines for LITT allowing access to a minimally invasive surgical option to its beneficiaries with refractory epilepsy when the established medical necessity criteria have been met.
-
AOBiome Therapeutics Announces Appointment of Dr. Judith Ng Cashin as Chief Medical Officer
12/18/2018
Dr. Judith Ng Cashin, M.D., has joined the company as Chief Medical Officer effective as of October 1, 2018.
-
Enteris BioPharma to Present at Biotech Showcase 2019
12/18/2018
Joel Tune, will present at Biotech Showcase 2019 to be held January 6-9, 2019, at the Hilton San Francisco Union Square.
-
Symbility Solutions is Acquired by CoreLogic
12/18/2018
Symbility Solutions Inc. ("Symbility") (TSXV: SY) announced that CoreLogic, Inc. ("CoreLogic") (NYSE: CLGX), through its indirect wholly owned subsidiary, 2154638 Alberta Ltd., has completed the acquisition of all of the issued and outstanding common shares of Symbility not already owned by it or its affiliates for a purchase price of $0.615 per common share.
-
VITAS Healthcare Selects Oracle Cloud Applications to Optimize Its Workforce Management Systems
12/18/2018
VITAS Healthcare, a leading provider of end-of-life care in the US, has selected Oracle Cloud Applications to streamline core business and finance functions, anticipate and respond to frequently changing workforce needs, and support career success for nearly 12,000 VITAS employees.
-
MinuteClinic Launches New Virtual Care Offering in New Mexico
12/18/2018
CVS Health (NYSE: CVS) today announced that MinuteClinic, the company's retail medical clinic, has rolled out its new virtual health care offering in the state of New Mexico
-
Propanc Biopharma Selects LaVoieHealthScience as Integrated Communications Partner
12/18/2018
Propanc Biopharma (OTCQB: PPCB) ("Propanc"), a clinical stage biopharmaceutical company focused on development of new and proprietary treatments for cancer patients suffering from solid tumors such as pancreatic, ovarian and colorectal cancers, today announced that Propanc has selected LaVoieHealthScience (“LHS”) as its communications agency of record.
-
First Patient Enrolled in Isofol's Pivotal Phase 3 AGENT Study in 1st Line Metastatic Colorectal Cancer
12/18/2018
AGENT is a randomized, controlled, multi-centre study with blinded independent review of the tumour response.
-
IoT Lab Forming to Grow Innovative Products, Businesses, New Markets in Indiana
12/18/2018
$750,000 U.S. Economic Development Administration Grant and Northeast Indiana Founding Partners Backing Lab/Network [18-December-2018] FORT WAYNE, Ind. , Dec. 18, 2018 Individuals and companies interested in developing products and businesses around the Health Internet of Things (IoT) will have a new option. The NIIC was awarded funding to launch a cluster-fo
-
Cipher Pharmaceuticals Announces A-101 40% Topical Solution Accepted for Review by Health Canada
12/18/2018
Cipher Pharmaceuticals Inc. announced that its New Drug Submission ("NDS") for A-101 40% topical solution ("A-101 40%") for the treatment of raised seborrheic keratoses ("SKs") has been accepted for review by Health Canada.
-
Cardiva Medical Announces FDA Approval of the VASCADE MVP Vascular Closure System for Multi-Site Vessel Closure Following Electrophysiology Procedures
12/18/2018
VASCADE MVP is the first vessel closure technology designed for electrophysiology procedures – and proven by electrophysiology physicians in a multi-center, randomized, controlled clinical trial.
-
Pharma Companies Can Cut Clinical Trial Randomization Set Up 89 Percent with Oracle
12/18/2018
The complexity of clinical research and development has increased exponentially, putting a strain on outdated systems used to support the business processes required to conduct a clinical trial.
-
MinuteClinic Launches New Virtual Care Offering in Wyoming
12/18/2018
CVS Health (NYSE: CVS) today announced that MinuteClinic, the company's retail medical clinic, has rolled out its new virtual health care offering in the state of Wyoming.
-
Inogen Announces Launch of Inogen Connect
12/18/2018
Inogen (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced the commercial launch of Inogen Connect.
-
Genetic Immunity Grants Exclusive License of Therapeutic HIV Vaccine Technology to JSC Pharmadis for Russia and Commonwealth of Independent States
12/18/2018
Pharmadis received rights to market Genetic Immunity's HIV technology in Russia and the Commonwealth of Independent States
-
Encoda Acquires Revenue Cycle Management Services Division from Microwize Technology
12/18/2018
Microwize Technology is a physician services organization whose services include revenue cycle management, healthcare IT, hosting services, physician credentialing, and EMR/EHR user implementation and training.
-
INSIGHTEC Announces FDA Approval of Exablate Neuro for the Treatment of Tremor-Dominant Parkinson's Disease
12/18/2018
The device is indicated for unilateral thalamotomy with medication-refractory tremor patients
-
Hemp Legalization to Open New Markets for Digipath
12/18/2018
Digipath, Inc. (OTCQB: DIGP), a service-oriented independent testing laboratory and data firm focused on the developing cannabis and hemp markets, is pleased to announce its support of Congress's Farm Bill, which legalizes the production and sale of hemp.